TOMD.F Stock Overview
A vitro diagnostics company, develops and commercializes blood tests for the detection of cancer and Alzheimer disease in the United States. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 0/6 |
| Dividends | 0/6 |
Todos Medical Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$0.000001 |
| 52 Week High | US$0.0005 |
| 52 Week Low | US$0.000001 |
| Beta | 0 |
| 11 Month Change | 0% |
| 3 Month Change | -99.00% |
| 1 Year Change | -99.75% |
| 33 Year Change | -100.00% |
| 5 Year Change | -100.00% |
| Change since IPO | -100.00% |
Recent News & Updates
Recent updates
Shareholder Returns
| TOMD.F | US Biotechs | US Market | |
|---|---|---|---|
| 7D | 0% | 2.4% | 0.5% |
| 1Y | -99.8% | 15.6% | 30.7% |
Return vs Industry: TOMD.F underperformed the US Biotechs industry which returned 18.8% over the past year.
Return vs Market: TOMD.F underperformed the US Market which returned 32.3% over the past year.
Price Volatility
| TOMD.F volatility | |
|---|---|
| TOMD.F Average Weekly Movement | 5,534.7% |
| Biotechs Industry Average Movement | 9.9% |
| Market Average Movement | 6.3% |
| 10% most volatile stocks in US Market | 16.3% |
| 10% least volatile stocks in US Market | 3.1% |
Stable Share Price: TOMD.F's share price has been volatile over the past 3 months compared to the US market.
Volatility Over Time: TOMD.F's weekly volatility has increased from 3279% to 5535% over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2010 | n/a | Gerald Commissiong | todosmedical.com |
Todos Medical Ltd., a vitro diagnostics company, develops and commercializes blood tests for the detection of cancer and Alzheimer disease in the United States. The company develops Total Biochemical Infrared Analysis, a proprietary cancer-screening technology using peripheral blood spectroscopy analysis for examination into cancer’s influence on the immune system; Lymphocyte Proliferation Test, a diagnostic blood test that determines the ability of peripheral blood lymphocytes and monocytes to withstand an exogenous mitogenic stimulation that induces them to enter the cell cycle; and blood tests for the detection of neurodegenerative disorders, such as Alzheimer's disease. Its cancer screening and diagnosis products include TM-B1 and TM-B2 for breast cancer tests; and TMC blood test for the screening and diagnosis of colon cancer.
Todos Medical Ltd. Fundamentals Summary
| TOMD.F fundamental statistics | |
|---|---|
| Market cap | US$3.32k |
| Earnings (TTM) | -US$38.77m |
| Revenue (TTM) | US$10.75m |
0.0x
P/S Ratio0.0x
P/E RatioIs TOMD.F overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| TOMD.F income statement (TTM) | |
|---|---|
| Revenue | US$10.75m |
| Cost of Revenue | US$6.27m |
| Gross Profit | US$4.48m |
| Other Expenses | US$43.25m |
| Earnings | -US$38.77m |
Last Reported Earnings
Sep 30, 2022
Next Earnings Date
n/a
| Earnings per share (EPS) | 0 |
| Gross Margin | 0.00% |
| Net Profit Margin | 0.00% |
| Debt/Equity Ratio | 0.0% |
How did TOMD.F perform over the long term?
See historical performance and comparison